Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Net Cash Flow (2021 - 2025)

Biote (BTMD) has 5 years of Net Cash Flow data on record, last reported at $8.4 million in Q3 2025.

  • For Q3 2025, Net Cash Flow fell 28.5% year-over-year to $8.4 million; the TTM value through Sep 2025 reached -$10.2 million, up 62.77%, while the annual FY2024 figure was -$49.6 million, 607.03% down from the prior year.
  • Net Cash Flow reached $8.4 million in Q3 2025 per BTMD's latest filing, up from -$22.1 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $55.0 million in Q2 2022 and bottomed at -$52.4 million in Q2 2024.
  • Average Net Cash Flow over 5 years is $573052.6, with a median of $1.1 million recorded in 2024.
  • Peak YoY movement for Net Cash Flow: tumbled 1812.05% in 2022, then soared 1228.06% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at $3.8 million in 2021, then crashed by 54.1% to $1.8 million in 2022, then skyrocketed by 1228.06% to $23.4 million in 2023, then plummeted by 95.21% to $1.1 million in 2024, then soared by 652.18% to $8.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $8.4 million in Q3 2025, -$22.1 million in Q2 2025, and $2.4 million in Q1 2025.